100
Participants
Start Date
March 3, 2017
Primary Completion Date
September 30, 2020
Study Completion Date
September 30, 2021
Temsirolimus
After completion of revascularization therapy and any decision to place stents, patients will be qualified for final enrollment in the study and will be treated with the investigational drug or saline. Investigators will be blinded to assignment.
Saline
After completion of revascularization therapy and any decision to place stents, patients will be qualified for final enrollment in the study and will be treated with the investigational drug or saline. Investigators will be blinded to assignment.
Einstein Medical Center, Philadelphia
University Hospital, Cleveland
Sanford Research, Sioux Falls
Advocate Christ Medical Center, Oak Lawn
Arkansas Heart Hospital, Little Rock
Baylor College of Medicine, Houston
Denver Veterans Administration Hospital, Denver
St. Joseph Hospital of Orange Heart and Vascular Center, Orange
Lead Sponsor
Mercator MedSystems, Inc.
INDUSTRY